Nikolay Savchuk

life science layman

[Nikolay Savchuk @Savchuk_TPI]

i2020 accelerator's Context Therapeutics a women’s oncology company announced IPO https://t.co/hV1xHlUefT

[Nikolay Savchuk @Savchuk_TPI]

Join us on Sept 2nd as our portfolio company GALE/019Labs launches the world's first remote point-of-care solution to combine this #tech with an open suite of FDA-approved devices.

Register now! https://t.co/zrfKuQg3Si

#AI #DigitalHealth

[Nikolay Savchuk @Savchuk_TPI]

#Viriom and partners published results of a successful Proof Of Concept clinical trial of #Aprotinin in severe #COVID19 patients. Both #Aprotinin and its combination with direct antiviral treatment #Avifavir are stable to mAb #resistant #SARS-CoV2 #mutations.

[Nikolay Savchuk @Savchuk_TPI]

NeuraLace a Teal Ventures' Portfolio Company Announces FDA 510(k) Clearance and U.S. Launch of Axon Therapy® Peripheral Nerve Stimulation System For Chronic Pain Relief
https://t.co/DWpUJVuenV

[Nikolay Savchuk @Savchuk_TPI]

#i2020accelerator of San Diego CA expanded Loch development platform investing 8 startups together with OrbiMed Advisors and BioGeneration Ventures targeting #cancer, #autoimmunity and #neurodegeneration.
https://t.co/B05TGuWzzc

[Nikolay Savchuk @Savchuk_TPI]

Viriom' affiliate Chromis ( a JV of ChemRar Group and Russian Direct Investment Fund) obtained first marketing approval in Russia for #Avifavir (200mg oral daily tablets) - a direct #antiviral treatment of #COVID19 targeting viral RNA polymerase. https://t.co/JLCnEsgOYe

[Nikolay Savchuk @Savchuk_TPI]

Viriom Announces Initiation of Phase 2 Study Investigating Efficacy of Intramuscular Long-Acting Injectable Nanofo... https://t.co/Ws6iK0uBAW

[Nikolay Savchuk @Savchuk_TPI]

Viriom and China CDC' contractors from Zhejiang University found Elpida ( elsulfavirine) active against COVID-19 to initiate Phase 2 clinical tria - https://t.co/URWUQakx21. #clinicaltrial #covid-19, #covid19

[Nikolay Savchuk @Savchuk_TPI]

Viriom to Report Results from Phase 1b Clinical Trial of Once Weekly Oral HIV Treatment https://t.co/dgFqGnPvcD

[Nikolay Savchuk @Savchuk_TPI]

Viriom initiated Ph 1 clinical trial of long acting injectable HIV treatment. https://t.co/JjG7gCyX1s?

[Nikolay Savchuk @Savchuk_TPI]

Torrey Pines'​ i2020 Accelerator to Advance Snap Bio's Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases https://t.co/EGXSU1kEWS

[Nikolay Savchuk @Savchuk_TPI]

I'm going to "FDA Regulatory Strategies and CMC Considerations - Inaugural IRISYS Educational...". See you there? https://t.co/6YbbfdLdPX с помощью @Eventbrite

[Nikolay Savchuk @Savchuk_TPI]

Viriom will Present Data on VM1500A LAI Formulation to treat HIV-1 in Milano and launch Elpida® (Elsulfavirine) in first developing markets

[Nikolay Savchuk @Savchuk_TPI]

@The_ingarr @ChupinZenitco @MedTechGuru @gnatashechka думаю последнее

[Nikolay Savchuk @Savchuk_TPI]

@Torrey Pines Investment Establishes a $60 Million TealTech Capital Fund to Support Point-of-Care Medicine https://t.co/yNksk7pTWX

[Nikolay Savchuk @Savchuk_TPI]

"Viriom to Present Positive Clinical Findings for Elpida® vs Efavirenz in Combination with TDF/FTC" https://t.co/KPjXz8bd35 on @LinkedIn

[Nikolay Savchuk @Savchuk_TPI]

"Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases" https://t.co/af6WMKzgxc on @LinkedIn

[Nikolay Savchuk @Savchuk_TPI]

https://t.co/BPU0udPYpY @chupinzenitco, @the_ingarr, @medtechguru, @gnatashechka